Previous 10 | Next 10 |
Aditxt Inc. (ADTX) is expected to report $-5.99 for Q3 2023
2023-11-08 10:13:06 ET More on Aditx Therapeutics Aditxt appoints Ernie Lee as CEO of its wholly-owned subsidiary, Pearsanta Aditxt stock drops 48% on $10M private placement Seeking Alpha’s Quant Rating on Aditx Therapeutics For further details see: ...
Aditxt (NASDAQ: ADTX) is an innovation activation company focused on the discovery, development and deployment of technologies that monitor and modulate the immune system. The company today announced that it will present at the 8th Annual Dawson James Conference on Thursday, Oct. 12, 2023, at th...
Richmond, VA, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt” or the "Company"), an innovation activation company focused on the discovery, development, and deployment of technologies that monitor and modulate the immune system will present at the 8th Annual Dawson ...
2023-10-05 08:36:13 ET More on Aditx Therapeutics Aditxt stock drops 48% on $10M private placement Aditxt announces 1-for-40 reverse stock split Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earnings data for Aditx Therapeutics ...
Aditxt, Inc., (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation activation company focused on the discovery, development, and deployment of technologies that monitor and modulate the immune system, announced today that it has appointed Ernie Lee to serv...
2023-09-28 10:00:05 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...
2023-09-22 09:59:56 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
2023-09-15 16:44:31 ET More on Aditx Therapeutics Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earnings data for Aditx Therapeutics Financial information for Aditx Therapeutics Aditxt stock drops 48% on $10M private placement A...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
Aditxt (NASDAQ: ADTX) , a company dedicated to discovering, developing and deploying promising health innovations, and Evofem Biosciences Inc. (OTCQB: EVFM) are announcing a new market partnership with Hello Alpha, a telemedicine company with a medical team specifically trained f...
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare PR Newswire — Leading telemedicine company expands offering with hormone-free birth control as GLP-1 medication usage increases ...
Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...